Thiazolidinedione use, fluid retention, and congestive heart failure: A consensus statement from the American Heart Association and American Diabetes Association
Gespeichert in:
| Veröffentlicht in: | Diabetes care 2004, Vol.27 (1), p.256-263 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 263 |
|---|---|
| container_issue | 1 |
| container_start_page | 256 |
| container_title | Diabetes care |
| container_volume | 27 |
| creator | NESTO, Richard W BELL, David YOUNG, Lawrence H KAHN, Richard BONOW, Robert O FONSECA, Vivian GRUNDY, Scott M HORTON, Edward S LE WINTER, Martin PORTE, Daniel SEMENKOVICH, Clay F SMITH, Sidney |
| description | |
| doi_str_mv | 10.2337/diacare.27.1.256 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_gale_infotracmisc_A112312360</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A112312360</galeid><sourcerecordid>A112312360</sourcerecordid><originalsourceid>FETCH-LOGICAL-g259t-27421efebd69bdf28b4abc8b71469aad7cad43cff3748718157690b3afea44193</originalsourceid><addsrcrecordid>eNptkk1r3DAQhkVpabZp7z0VQektdq0PW1JvJmmbQqCX9LyMpdGuii0HyQ60_6b_NNok_YJFAsHM876DZoaQ16ypuRDqvQtgIWHNVc1q3nZPyIYZ0VZtK_VTsmmYNFVrDD8hL3L-3jSNlFo_JydMdkYYozfk1_U-wM95DC5EdGGOSNeMZ9SPa3A04YJxKdEzCtFRO8cd5iXcIt0jpIV6COOa8APtD7mMMa-Z5gUWnIqO-jRPdNkj7SdMwUKkl_eyPufZBjgY3_v-SV8EGErJ_C_xkjzzMGZ89fiekm-fPl6fX1ZXXz9_Oe-vqh1vzVJxJTlDj4PrzOA814OEwepBHf4K4JQFJ4X1XiipFdOsVZ1pBgEeQcrStVPy9sF3ByNuQ_TzksBOIdttzxgX5XZNoaoj1A4jJhhL93wo4f_4-ghfjsMp2KOCNw-Cm3WY0G1vUpgg_dj-HlkB3j0CkC2MPkG0If_lWqG5KttxB7ScqIQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Thiazolidinedione use, fluid retention, and congestive heart failure: A consensus statement from the American Heart Association and American Diabetes Association</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>NESTO, Richard W ; BELL, David ; YOUNG, Lawrence H ; KAHN, Richard ; BONOW, Robert O ; FONSECA, Vivian ; GRUNDY, Scott M ; HORTON, Edward S ; LE WINTER, Martin ; PORTE, Daniel ; SEMENKOVICH, Clay F ; SMITH, Sidney</creator><creatorcontrib>NESTO, Richard W ; BELL, David ; YOUNG, Lawrence H ; KAHN, Richard ; BONOW, Robert O ; FONSECA, Vivian ; GRUNDY, Scott M ; HORTON, Edward S ; LE WINTER, Martin ; PORTE, Daniel ; SEMENKOVICH, Clay F ; SMITH, Sidney</creatorcontrib><identifier>ISSN: 0149-5992</identifier><identifier>EISSN: 1935-5548</identifier><identifier>DOI: 10.2337/diacare.27.1.256</identifier><identifier>PMID: 14693998</identifier><identifier>CODEN: DICAD2</identifier><language>eng</language><publisher>Alexandria, VA: American Diabetes Association</publisher><subject>Biological and medical sciences ; Cardiology. Vascular system ; Complications and side effects ; Congestive heart failure ; Diabetes. Impaired glucose tolerance ; Edema - chemically induced ; Edema - epidemiology ; Endocrine pancreas. Apud cells (diseases) ; Endocrinopathies ; Heart ; Heart Failure - chemically induced ; Heart Failure - epidemiology ; Heart failure, cardiogenic pulmonary edema, cardiac enlargement ; Humans ; Hypoglycemic Agents - adverse effects ; Medical sciences ; Physiological aspects ; Risk factors ; Safety ; Thiazolidinediones ; Thiazolidinediones - adverse effects ; Type 2 diabetes ; Weight Gain</subject><ispartof>Diabetes care, 2004, Vol.27 (1), p.256-263</ispartof><rights>2004 INIST-CNRS</rights><rights>COPYRIGHT 2004 American Diabetes Association</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010,27900,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15382723$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14693998$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>NESTO, Richard W</creatorcontrib><creatorcontrib>BELL, David</creatorcontrib><creatorcontrib>YOUNG, Lawrence H</creatorcontrib><creatorcontrib>KAHN, Richard</creatorcontrib><creatorcontrib>BONOW, Robert O</creatorcontrib><creatorcontrib>FONSECA, Vivian</creatorcontrib><creatorcontrib>GRUNDY, Scott M</creatorcontrib><creatorcontrib>HORTON, Edward S</creatorcontrib><creatorcontrib>LE WINTER, Martin</creatorcontrib><creatorcontrib>PORTE, Daniel</creatorcontrib><creatorcontrib>SEMENKOVICH, Clay F</creatorcontrib><creatorcontrib>SMITH, Sidney</creatorcontrib><title>Thiazolidinedione use, fluid retention, and congestive heart failure: A consensus statement from the American Heart Association and American Diabetes Association</title><title>Diabetes care</title><addtitle>Diabetes Care</addtitle><subject>Biological and medical sciences</subject><subject>Cardiology. Vascular system</subject><subject>Complications and side effects</subject><subject>Congestive heart failure</subject><subject>Diabetes. Impaired glucose tolerance</subject><subject>Edema - chemically induced</subject><subject>Edema - epidemiology</subject><subject>Endocrine pancreas. Apud cells (diseases)</subject><subject>Endocrinopathies</subject><subject>Heart</subject><subject>Heart Failure - chemically induced</subject><subject>Heart Failure - epidemiology</subject><subject>Heart failure, cardiogenic pulmonary edema, cardiac enlargement</subject><subject>Humans</subject><subject>Hypoglycemic Agents - adverse effects</subject><subject>Medical sciences</subject><subject>Physiological aspects</subject><subject>Risk factors</subject><subject>Safety</subject><subject>Thiazolidinediones</subject><subject>Thiazolidinediones - adverse effects</subject><subject>Type 2 diabetes</subject><subject>Weight Gain</subject><issn>0149-5992</issn><issn>1935-5548</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkk1r3DAQhkVpabZp7z0VQektdq0PW1JvJmmbQqCX9LyMpdGuii0HyQ60_6b_NNok_YJFAsHM876DZoaQ16ypuRDqvQtgIWHNVc1q3nZPyIYZ0VZtK_VTsmmYNFVrDD8hL3L-3jSNlFo_JydMdkYYozfk1_U-wM95DC5EdGGOSNeMZ9SPa3A04YJxKdEzCtFRO8cd5iXcIt0jpIV6COOa8APtD7mMMa-Z5gUWnIqO-jRPdNkj7SdMwUKkl_eyPufZBjgY3_v-SV8EGErJ_C_xkjzzMGZ89fiekm-fPl6fX1ZXXz9_Oe-vqh1vzVJxJTlDj4PrzOA814OEwepBHf4K4JQFJ4X1XiipFdOsVZ1pBgEeQcrStVPy9sF3ByNuQ_TzksBOIdttzxgX5XZNoaoj1A4jJhhL93wo4f_4-ghfjsMp2KOCNw-Cm3WY0G1vUpgg_dj-HlkB3j0CkC2MPkG0If_lWqG5KttxB7ScqIQ</recordid><startdate>2004</startdate><enddate>2004</enddate><creator>NESTO, Richard W</creator><creator>BELL, David</creator><creator>YOUNG, Lawrence H</creator><creator>KAHN, Richard</creator><creator>BONOW, Robert O</creator><creator>FONSECA, Vivian</creator><creator>GRUNDY, Scott M</creator><creator>HORTON, Edward S</creator><creator>LE WINTER, Martin</creator><creator>PORTE, Daniel</creator><creator>SEMENKOVICH, Clay F</creator><creator>SMITH, Sidney</creator><general>American Diabetes Association</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>2004</creationdate><title>Thiazolidinedione use, fluid retention, and congestive heart failure: A consensus statement from the American Heart Association and American Diabetes Association</title><author>NESTO, Richard W ; BELL, David ; YOUNG, Lawrence H ; KAHN, Richard ; BONOW, Robert O ; FONSECA, Vivian ; GRUNDY, Scott M ; HORTON, Edward S ; LE WINTER, Martin ; PORTE, Daniel ; SEMENKOVICH, Clay F ; SMITH, Sidney</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g259t-27421efebd69bdf28b4abc8b71469aad7cad43cff3748718157690b3afea44193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Biological and medical sciences</topic><topic>Cardiology. Vascular system</topic><topic>Complications and side effects</topic><topic>Congestive heart failure</topic><topic>Diabetes. Impaired glucose tolerance</topic><topic>Edema - chemically induced</topic><topic>Edema - epidemiology</topic><topic>Endocrine pancreas. Apud cells (diseases)</topic><topic>Endocrinopathies</topic><topic>Heart</topic><topic>Heart Failure - chemically induced</topic><topic>Heart Failure - epidemiology</topic><topic>Heart failure, cardiogenic pulmonary edema, cardiac enlargement</topic><topic>Humans</topic><topic>Hypoglycemic Agents - adverse effects</topic><topic>Medical sciences</topic><topic>Physiological aspects</topic><topic>Risk factors</topic><topic>Safety</topic><topic>Thiazolidinediones</topic><topic>Thiazolidinediones - adverse effects</topic><topic>Type 2 diabetes</topic><topic>Weight Gain</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>NESTO, Richard W</creatorcontrib><creatorcontrib>BELL, David</creatorcontrib><creatorcontrib>YOUNG, Lawrence H</creatorcontrib><creatorcontrib>KAHN, Richard</creatorcontrib><creatorcontrib>BONOW, Robert O</creatorcontrib><creatorcontrib>FONSECA, Vivian</creatorcontrib><creatorcontrib>GRUNDY, Scott M</creatorcontrib><creatorcontrib>HORTON, Edward S</creatorcontrib><creatorcontrib>LE WINTER, Martin</creatorcontrib><creatorcontrib>PORTE, Daniel</creatorcontrib><creatorcontrib>SEMENKOVICH, Clay F</creatorcontrib><creatorcontrib>SMITH, Sidney</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Diabetes care</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>NESTO, Richard W</au><au>BELL, David</au><au>YOUNG, Lawrence H</au><au>KAHN, Richard</au><au>BONOW, Robert O</au><au>FONSECA, Vivian</au><au>GRUNDY, Scott M</au><au>HORTON, Edward S</au><au>LE WINTER, Martin</au><au>PORTE, Daniel</au><au>SEMENKOVICH, Clay F</au><au>SMITH, Sidney</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Thiazolidinedione use, fluid retention, and congestive heart failure: A consensus statement from the American Heart Association and American Diabetes Association</atitle><jtitle>Diabetes care</jtitle><addtitle>Diabetes Care</addtitle><date>2004</date><risdate>2004</risdate><volume>27</volume><issue>1</issue><spage>256</spage><epage>263</epage><pages>256-263</pages><issn>0149-5992</issn><eissn>1935-5548</eissn><coden>DICAD2</coden><cop>Alexandria, VA</cop><pub>American Diabetes Association</pub><pmid>14693998</pmid><doi>10.2337/diacare.27.1.256</doi><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0149-5992 |
| ispartof | Diabetes care, 2004, Vol.27 (1), p.256-263 |
| issn | 0149-5992 1935-5548 |
| language | eng |
| recordid | cdi_gale_infotracmisc_A112312360 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Biological and medical sciences Cardiology. Vascular system Complications and side effects Congestive heart failure Diabetes. Impaired glucose tolerance Edema - chemically induced Edema - epidemiology Endocrine pancreas. Apud cells (diseases) Endocrinopathies Heart Heart Failure - chemically induced Heart Failure - epidemiology Heart failure, cardiogenic pulmonary edema, cardiac enlargement Humans Hypoglycemic Agents - adverse effects Medical sciences Physiological aspects Risk factors Safety Thiazolidinediones Thiazolidinediones - adverse effects Type 2 diabetes Weight Gain |
| title | Thiazolidinedione use, fluid retention, and congestive heart failure: A consensus statement from the American Heart Association and American Diabetes Association |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T22%3A32%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Thiazolidinedione%20use,%20fluid%20retention,%20and%20congestive%20heart%20failure:%20A%20consensus%20statement%20from%20the%20American%20Heart%20Association%20and%20American%20Diabetes%20Association&rft.jtitle=Diabetes%20care&rft.au=NESTO,%20Richard%20W&rft.date=2004&rft.volume=27&rft.issue=1&rft.spage=256&rft.epage=263&rft.pages=256-263&rft.issn=0149-5992&rft.eissn=1935-5548&rft.coden=DICAD2&rft_id=info:doi/10.2337/diacare.27.1.256&rft_dat=%3Cgale_pubme%3EA112312360%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/14693998&rft_galeid=A112312360&rfr_iscdi=true |